Lifecore Biomedical, Inc.
LFCR· Nasdaq
LFCRLifecore Biomedical, Inc.
Filed Aug 7, 2013 · 10-K · 73 days after period end · 0001437749-13-010047
| Metric | Q4 2013 | Q4 2012 | Q4 2011dderived from reported figures |
|---|---|---|---|
| Revenue | $107.11M | $82.62M | — |
| Net Income | $4.52M | — | — |
| EPS Diluted | $0.17 | $0.11 | — |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Lifecore Biomedical, Inc. · CIK 1005286 · Engraved from SEC EDGAR
ended May 26, 2013 · filed Aug 7, 2013 · 73 d after period end
